HealthLeaders Media May 4, 2022
Vital signs sticker aims to detect early signs of trouble, including infection, in bone marrow transplant recipients.
KEY TAKEAWAYS
Predictive analytics, portable imaging, and telemedicine round out technology utilization.
Study compensates to recognize that typical body temperature can vary from patient to patient.
Trial will start in Denver metro area, but ultimately could lead to regional remote monitoring services.
A Colorado health system is testing the feasibility of remote patient monitoring for the early detection of febrile neutropenia, a common, life-threatening complication of cancer therapy that is typically treated as an oncologic emergency.
Ten bone-marrow transplant recipients will initially participate in the trial at the University of Colorado Anschutz Medical Campus, also known as CU Anschutz. The phased approach, through...